These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 15543082

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Transport characteristics of grepafloxacin and levofloxacin in the human intestinal cell line Caco-2.
    Yamaguchi H, Yano I, Saito H, Inui K.
    Eur J Pharmacol; 2001 Nov 23; 431(3):297-303. PubMed ID: 11730721
    [Abstract] [Full Text] [Related]

  • 4. Circumventing P-glycoprotein-mediated cellular efflux of quinidine by prodrug derivatization.
    Jain R, Majumdar S, Nashed Y, Pal D, Mitra AK.
    Mol Pharm; 2004 Nov 23; 1(4):290-9. PubMed ID: 15981588
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. In vitro and in vivo investigations on fluoroquinolones; effects of the P-glycoprotein efflux transporter on brain distribution of sparfloxacin.
    de Lange EC, Marchand S, van den Berg D, van der Sandt IC, de Boer AG, Delon A, Bouquet S, Couet W.
    Eur J Pharm Sci; 2000 Dec 23; 12(2):85-93. PubMed ID: 11102735
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The H2 receptor antagonist nizatidine is a P-glycoprotein substrate: characterization of its intestinal epithelial cell efflux transport.
    Dahan A, Sabit H, Amidon GL.
    AAPS J; 2009 Jun 23; 11(2):205-13. PubMed ID: 19319690
    [Abstract] [Full Text] [Related]

  • 12. Limited distribution of new quinolone antibacterial agents into brain caused by multiple efflux transporters at the blood-brain barrier.
    Tamai I, Yamashita J, Kido Y, Ohnari A, Sai Y, Shima Y, Naruhashi K, Koizumi S, Tsuji A.
    J Pharmacol Exp Ther; 2000 Oct 23; 295(1):146-52. PubMed ID: 10991972
    [Abstract] [Full Text] [Related]

  • 13. Role of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza Bunge.
    Yu XY, Lin SG, Zhou ZW, Chen X, Liang J, Liu PQ, Duan W, Chowbay B, Wen JY, Li CG, Zhou SF.
    Curr Drug Metab; 2007 May 23; 8(4):325-40. PubMed ID: 17504222
    [Abstract] [Full Text] [Related]

  • 14. Binding characteristics of fluoroquinolones to synthetic levodopa melanin.
    Ono C, Tanaka M.
    J Pharm Pharmacol; 2003 Aug 23; 55(8):1127-33. PubMed ID: 12956903
    [Abstract] [Full Text] [Related]

  • 15. Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors.
    Profit L, Eagling VA, Back DJ.
    AIDS; 1999 Sep 10; 13(13):1623-7. PubMed ID: 10509562
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Multiple pathways for fluoroquinolone secretion by human intestinal epithelial (Caco-2) cells.
    Lowes S, Simmons NL.
    Br J Pharmacol; 2002 Mar 10; 135(5):1263-75. PubMed ID: 11877335
    [Abstract] [Full Text] [Related]

  • 20. Characterization of the efflux transporter(s) responsible for restricting intestinal mucosa permeation of the coumarinic acid-based cyclic prodrug of the opioid peptide DADLE.
    Tang F, Borchardt RT.
    Pharm Res; 2002 Jun 10; 19(6):787-93. PubMed ID: 12134948
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.